ABSTRACT NUMBER: ESOC2026A521 ASSOCIATION BETWEEN LIPID-LOWERING THERAPY AND INCREASED CEREBRAL MICROBLEEDS: A LONGITUDINAL BRAIN HEALTH SCREENING COHORT STUDY IN JAPAN
Shuhei Ikeda, Yusuke Yakushiji, Masaaki Chiku, Ryuji Kawata, Hidekazu Tomimoto, Fusao Ikawa · 2026
Read ABSTRACT NUMBER: ESOC2026A521 ASSOCIATION BETWEEN LIPID-LOWERING THERAPY AND INCREASED CEREBRAL MICROBLEEDS: A LONGITUDINAL BRAIN HEALTH SCREENING COHORT STUDY IN JAPAN by Shuhei Ikeda, Yusuke Yakushiji, Masaaki Chiku, Ryuji Kawata, Hidekazu Tomimoto, Fusao Ikawa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145695.txt.
Description
Shuhei Ikeda and co-authors present a 2026 conference study on cholesterol drugs and tiny brain bleeds in Japan. Small bleeds in the brain mark fragile vessels, but whether lipid-lowering therapy speeds their growth was unclear, above all in middle-aged people taking the drugs for prevention. The team drew on a brain health screening program and kept 2,350 adults with high lipids and no past stroke who had at least two MRI scans.
About forty-three percent used lipid-lowering drugs. Over a median follow-up near thirty-three months, users faced about twice the rate of bleed growth, after weighting and adjustment. Other vessel-disease marks, such as white matter scars, did not progress faster in users. The authors flag a risk to weigh against the drugs' proven heart gains.
Catalog record
| CREATOR | Shuhei Ikeda, Yusuke Yakushiji, Masaaki Chiku, Ryuji Kawata, Hidekazu Tomimoto, Fusao Ikawa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |